ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities

Research Published in Radiology Shows that Combination of Transpara-based Lesion Detection, Volumetric Density and Quantitative Texture Analysis Delivers Improved Breast Cancer Risk Prediction NIJMEGEN, The Netherlands, Jan. 8, 2025 /PRNewswire/ — ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, development and implementation of quantitative imaging biomarkers. After […] L'articolo ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities proviene da La Ragione.

CONTINUA A LEGGERE